We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Supportive Therapy for Adherence to ART(STAART)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00212940
Recruitment Status : Completed
First Posted : September 21, 2005
Last Update Posted : July 26, 2007
Information provided by:

September 13, 2005
September 21, 2005
July 26, 2007
October 2000
Not Provided
psycho-educational intervention can help people living with HIV handle the changes of treatment adherence
Not Provided
Complete list of historical versions of study NCT00212940 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
Supportive Therapy for Adherence to ART(STAART)
Increasing Patient Adherence to HIV Medications: A Prospective Intervention Study
The purpose of this study is to determine whether a psycho-educational intervention can help people living with HIV handle the changes of treatment adherence.

Participants will be randomly assigned to one of two study groups:

  • Group 1: participants in this group will engage in weekly psycho-educational sessions with an HIV therapist for four weeks prior to starting their regimens. The sessions will cover topics such as becoming active in treatment care, improving coping abilities and developing skills for treatment adherence. They will also involve questionnaires and readings.
  • Group 2 (the control group):participants in this group will simply receive their regular treatment regimens.
Not Provided
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
HIV Infections
Behavioral: Supportive Therapy for Adherence to ART (behavior)
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
September 2006
Not Provided

Inclusion Criteria:

  • be at least 18 years of age
  • have viral load above 500 copies/ml
  • not be currently on HAART
  • be able to read and speak English/French

Exclusion Criteria:

  • current Substance Abuse
  • actively psychotic or suicidal
Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
Contact information is only displayed when the study is recruiting subjects
CIHR app# 1262000 ICE:
Not Provided
Not Provided
Not Provided
Not Provided
Ottawa Hospital Research Institute
Ontario HIV Treatment Network
Principal Investigator: William Cameron, MD OHRI
Ottawa Hospital Research Institute
July 2007

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP